A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma

Figure 4

Prognostic analysis of the five-lncRNA signature in three sets. (a–c) The curves of risk score in the training set, the testing set, and the whole set. The dotted line represents the cutoff score and divides the patients into the low-risk and high-risk groups. (d–e) Survival status of the patients in the training set, the testing set, and the whole set. The orange dots represent dead patients while the green dots represent alive patients. More dead patients correspond to the higher risk score. (g–i) Boxplots of the expression profiles of the five PIDElncRNAs in the training set, the testing set, and the whole set. (j–l) Kaplan-Meier survival analysis of the five-lncRNA signature in the training set, the testing set, and the whole set. (m–o) Time-dependent ROC curves of the five-lncRNA signature in the training set, the testing set, and the whole set. PIDElncRNAs: prognostic immune-related differentially expressed lncRNAs; ROC: receiver operating characteristic.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)